Word: respondents
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...about how that's going to be received? He had a genetic abnormality, and that abnormality could have resulted in mental retardation and it also - the chances were more likely that you wouldn't have necessarily known anything was wrong. I expect that people who are pro-life will respond negatively, and, in fact, I'd sort of be disappointed if they didn't. But when I went through this experience, it was so ... to use the word 'helpful' is ridiculous. It saved my life to know other women who had gone through it. If there's ever a point...
...Though the letter said that further legal action would be taken if BrunoBooks did not respond within seven days, Maddox said that Barnes & Noble has not followed up on its threats, although three months have passed...
...Maddox said that BrunoBooks is not planning to respond with legal action of its own, and is simply hoping that Barnes & Noble will retract the letter...
...customers don't respond, however, Thompson promises they'll be reminded of the value. "We are not going to sweep under the rug the affordability aspect," Thompson says. "This is a long-term awareness campaign. You will see everything from taste, indulgence, convenience and price point across the body of work that will be presented over the next couple of years." Yet the company has so far resisted franchisees that have been too explicit about price. Last year in Seattle, a group of McDonald's franchisees ran a billboard that read, "Four Bucks Is Dumb," a clear shot at Starbucks...
...STAR*D patients were taking citalopram, an SSRI marketed in North America as Celexa. Not surprisingly, those who met standard inclusion criteria for a clinical trial had significantly better outcomes on the drug. In the efficacy group, 52% responded to Celexa vs. 40% of the nonefficacy group. Patients in the latter group also took longer to respond and had to be readmitted to psychiatric settings more often. "Thus," the authors conclude, "current efficacy trials suggest a more optimistic outcome than is likely in practice, and the duration of adequate treatment suggested by data from efficacy trials may be too short...